Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 415 of 1,261
  1. US 10687520

    Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44

    The Board of Regents of the University of Texas System · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  2. US 10689377

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  3. US 10688181

    Cancer treatment combinations

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  4. US 10689422

    Recombinant polypeptide construct comprising multiple enterotoxigenic Escherichia coli fimbrial subunits

    United States of America as represented by the Secretary of the Air Force · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  5. US 10689346

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  6. US 10689646

    Treatment of genetic disorders associated with DNA repeat instability

    BIOMARIN TECHNOLOGIES B.V. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  7. US 10689456

    Anti-CD70 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  8. US 10689443

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  9. US 10689436

    Human antibodies to influenza hemagglutinin

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  10. US 10689717

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Therapeutics, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  11. US 10689595

    Synthesis and use of omega-hydroxylated polyunsaturated fatty acids

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  12. US 10689719

    Bifidobacterium longum

    PrecisionBiotics Group Limited · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  13. US 10689400

    Macrocycle kinase inhibitors

    TURNING POINT THERAPEUTICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  14. US 10689397

    ULK1 inhibitors and methods using same

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  15. US 10689419

    Process for the preparation of cyclic depsipeptides

    OnKure, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  16. US 10689414

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  17. US 10689413

    Composition enriched in single isomer of NUC-1031 and preparation method and use thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  18. US 10689373

    1,2-substituted cyclopentanes as orexin receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  19. US 10689357

    N-acylethanolamine hydrolyzing acid amidase (NAAA) inhibitors and use thereof

    Northwestern University · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  20. US 10689375

    Compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  21. US 10689352

    Solid state forms of trisodium valsartan: sacubitril

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  22. US 10689338

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  23. US 10688285

    Spinal subpial gene delivery system

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  24. US 10688184

    Methods and compositions for self-regulated release of active pharmaceutical ingredient

    Acurx Pharmaceuticals, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.